In conclusion, our findings demonstrate that irisin is involved in cartilage development and OA pathogenesis, and that the aberrant alteration of irisin expression in OA cartilage may imply that irisin could be a promising therapeutic target for treating bone and cartilage disorders including OA and rheumatoid arthritis (RA). Here, FNDC5 is linked to rheumatoid arthritis.